MANZURUL A. SIKDER MD NPI 1598885741

NPI Information

  • NPI: 1598885741
  • Provider Name: MANZURUL A. SIKDER, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1729 BURRSTONE ROAD
    SLOCUM DICKSON MEDICAL GROUP PLLC
    NEW HARTFORD, NY
    ZIP 13413
  • Phone: (315) 798-1500

Map and Directions

Get Directions

NPI Details

Manzurul A. Sikder, MD is a hematology and oncology internal medicine in New Hartford, NY with 22 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Manzurul A. Sikder, MD NPI is 1598885741. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1729 BURRSTONE ROAD
SLOCUM DICKSON MEDICAL GROUP PLLC
NEW HARTFORD, NY
ZIP 13413
Phone: (315) 798-1500
Fax: (315) 798-1707

The NPI 1598885741 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent derived from recombinant dna (HCPCS:90682)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Injection of drug or substance into vein (HCPCS:96374)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Blood smear interpretation by physician with written report (HCPCS:85060)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)

The enumeration date for this NPI number is 3/30/2007 and was last updated on 3/12/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology245286NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.